- CLDX Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Celldex Therapeutics (CLDX) 10-K/A2002 FY Annual report (amended)
Filed: 12 Sep 03, 12:00am
Exhibit 31.2
Certification
I, Avery W. Catlin, certify that:
1. I have reviewed this amendment no. 1 to the annual report on Form 10-K/A of AVANT Immunotherapeutics, Inc.; and
2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report.
Date: September 12, 2003 | /s/ Avery W. Catlin |
| |
|
| ||
| Name: | Avery W. Catlin | |
| Title: | Chief Financial Officer | |
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.